These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33319990)

  • 1. New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of
    Cheuka PM; Centani L; Arendse LB; Fienberg S; Wambua L; Renga SS; Dziwornu GA; Kumar M; Lawrence N; Taylor D; Wittlin S; Coertzen D; Reader J; van der Watt M; Birkholtz LM; Chibale K
    ACS Infect Dis; 2021 Jan; 7(1):34-46. PubMed ID: 33319990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for Inhibitor Potency and Selectivity of
    Fienberg S; Eyermann CJ; Arendse LB; Basarab GS; McPhail JA; Burke JE; Chibale K
    ACS Infect Dis; 2020 Nov; 6(11):3048-3063. PubMed ID: 32966036
    [No Abstract]   [Full Text] [Related]  

  • 3. Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.
    Green JL; Moon RW; Whalley D; Bowyer PW; Wallace C; Rochani A; Nageshan RK; Howell SA; Grainger M; Jones HM; Ansell KH; Chapman TM; Taylor DL; Osborne SA; Baker DA; Tatu U; Holder AA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1464-75. PubMed ID: 26711771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
    Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
    Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.
    Vanaerschot M; Murithi JM; Pasaje CFA; Ghidelli-Disse S; Dwomoh L; Bird M; Spottiswoode N; Mittal N; Arendse LB; Owen ES; Wicht KJ; Siciliano G; Bösche M; Yeo T; Kumar TRS; Mok S; Carpenter EF; Giddins MJ; Sanz O; Ottilie S; Alano P; Chibale K; Llinás M; Uhlemann AC; Delves M; Tobin AB; Doerig C; Winzeler EA; Lee MCS; Niles JC; Fidock DA
    Cell Chem Biol; 2020 Jul; 27(7):806-816.e8. PubMed ID: 32359426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide metabolism links cGMP-dependent protein kinase G to essential Ca²⁺ signals at key decision points in the life cycle of malaria parasites.
    Brochet M; Collins MO; Smith TK; Thompson E; Sebastian S; Volkmann K; Schwach F; Chappell L; Gomes AR; Berriman M; Rayner JC; Baker DA; Choudhary J; Billker O
    PLoS Biol; 2014 Mar; 12(3):e1001806. PubMed ID: 24594931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of the cGMP-dependent protein kinase in malaria parasites reveal a unique structural relay mechanism for activation.
    El Bakkouri M; Kouidmi I; Wernimont AK; Amani M; Hutchinson A; Loppnau P; Kim JJ; Flueck C; Walker JR; Seitova A; Senisterra G; Kakihara Y; Kim C; Blackman MJ; Calmettes C; Baker DA; Hui R
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14164-14173. PubMed ID: 31239348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission.
    Baker DA; Stewart LB; Large JM; Bowyer PW; Ansell KH; Jiménez-Díaz MB; El Bakkouri M; Birchall K; Dechering KJ; Bouloc NS; Coombs PJ; Whalley D; Harding DJ; Smiljanic-Hurley E; Wheldon MC; Walker EM; Dessens JT; Lafuente MJ; Sanz LM; Gamo FJ; Ferrer SB; Hui R; Bousema T; Angulo-Barturén I; Merritt AT; Croft SL; Gutteridge WE; Kettleborough CA; Osborne SA
    Nat Commun; 2017 Sep; 8(1):430. PubMed ID: 28874661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple
    Arendse LB; Murithi JM; Qahash T; Pasaje CFA; Godoy LC; Dey S; Gibhard L; Ghidelli-Disse S; Drewes G; Bantscheff M; Lafuente-Monasterio MJ; Fienberg S; Wambua L; Gachuhi S; Coertzen D; van der Watt M; Reader J; Aswat AS; Erlank E; Venter N; Mittal N; Luth MR; Ottilie S; Winzeler EA; Koekemoer LL; Birkholtz LM; Niles JC; Llinás M; Fidock DA; Chibale K
    Sci Transl Med; 2022 Oct; 14(667):eabo7219. PubMed ID: 36260689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening of the Plasmodium falciparum cGMP-dependent protein kinase identified a thiazole scaffold which kills erythrocytic and sexual stage parasites.
    Penzo M; de Las Heras-Dueña L; Mata-Cantero L; Diaz-Hernandez B; Vazquez-Muñiz MJ; Ghidelli-Disse S; Drewes G; Fernandez-Alvaro E; Baker DA
    Sci Rep; 2019 May; 9(1):7005. PubMed ID: 31065005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials.
    van der Watt ME; Reader J; Churchyard A; Nondaba SH; Lauterbach SB; Niemand J; Abayomi S; van Biljon RA; Connacher JI; van Wyk RDJ; Le Manach C; Paquet T; González Cabrera D; Brunschwig C; Theron A; Lozano-Arias S; Rodrigues JFI; Herreros E; Leroy D; Duffy J; Street LJ; Chibale K; Mancama D; Coetzer TL; Birkholtz LM
    J Antimicrob Chemother; 2018 May; 73(5):1279-1290. PubMed ID: 29420756
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Govindasamy K; Khan R; Snyder M; Lou HJ; Du P; Kudyba HM; Muralidharan V; Turk BE; Bhanot P
    Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.
    Bansal A; Ojo KK; Mu J; Maly DJ; Van Voorhis WC; Miller LH
    mBio; 2016 Dec; 7(6):. PubMed ID: 27923926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of allosteric inhibition in the
    Byun JA; Van K; Huang J; Henning P; Franz E; Akimoto M; Herberg FW; Kim C; Melacini G
    J Biol Chem; 2020 Jun; 295(25):8480-8491. PubMed ID: 32317283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplasmodial imidazopyridazines: structure-activity relationship studies lead to the identification of analogues with improved solubility and hERG profiles.
    Cheuka PM; Lawrence N; Taylor D; Wittlin S; Chibale K
    Medchemcomm; 2018 Oct; 9(10):1733-1745. PubMed ID: 30429978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.
    Brunschwig C; Lawrence N; Taylor D; Abay E; Njoroge M; Basarab GS; Le Manach C; Paquet T; Cabrera DG; Nchinda AT; de Kock C; Wiesner L; Denti P; Waterson D; Blasco B; Leroy D; Witty MJ; Donini C; Duffy J; Wittlin S; White KL; Charman SA; Jiménez-Díaz MB; Angulo-Barturen I; Herreros E; Gamo FJ; Rochford R; Mancama D; Coetzer TL; van der Watt ME; Reader J; Birkholtz LM; Marsh KC; Solapure SM; Burke JE; McPhail JA; Vanaerschot M; Fidock DA; Fish PV; Siegl P; Smith DA; Wirjanata G; Noviyanti R; Price RN; Marfurt J; Silue KD; Street LJ; Chibale K
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGMP Binding Domain D Mediates a Unique Activation Mechanism in Plasmodium falciparum PKG.
    Franz E; Knape MJ; Herberg FW
    ACS Infect Dis; 2018 Mar; 4(3):415-423. PubMed ID: 29251493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gametogenesis in malaria parasites is mediated by the cGMP-dependent protein kinase.
    McRobert L; Taylor CJ; Deng W; Fivelman QL; Cummings RM; Polley SD; Billker O; Baker DA
    PLoS Biol; 2008 Jun; 6(6):e139. PubMed ID: 18532880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P; Shah PK; Jo H; Lincoln TM
    J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.